integr generic inc said it wholli own develop corp subsidiari has sign letter intent with underwrit lafferti and inc and bayern and inc rais three mln dlrs through unit offer compani said each unit would consist two common share price about five dlrs each and warrant buy anoth share dlrs integr said would retain control interest integr said proceed would use financ develop prescript drug which patent expir reuter 